13F Holdings
中文EN

QTI QT IMAGING HOLDINGS, INC.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1844505 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY220.0%
TTM net income YoY8.2%
TTM EPS YoY58.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin40.4%
Operating margin-24.8%
Net margin-77.3%
FCF margin-48.2%
EBITDA margin-24.5%

Returns

ROE-2,125.0%
ROA-96.6%
ROIC (approx.)-98.7%
Asset turnover1.25x

Leverage & solvency

Liabilities / assets92.7%
Debt / equity5.07x
Current ratio3.10x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.61x
Accruals ratio-37.6%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$18.93M$4.88M$40,355$0—
Cost of revenue$10.34M$2.24M$134,988——
Gross profit$8.58M$2.64M-$94,633——
R&D expense$3.94M$3.27M$1.49M——
SG&A expense$9.09M$11.55M$3.43M$4.28M$1.08M
Operating income-$4.44M-$12.18M-$5.01M-$4.28M-$1.08M
Interest expense——$219,686$23,098—
Pretax income-$21.08M-$9.00M-$6.10M-$2.29M-$1.11M
Income tax-$1,000-$16,000$1,600$486,615$1,783
Net income-$21.08M-$8.98M-$6.10M-$2.77M-$1.11M
EBITDA-$4.31M-$11.95M-$4.53M——
EPS (basic)-2.01-2.13-0.64-0.60-0.14
EPS (diluted)-2.01-2.13-0.64-0.60-0.14
Weighted avg. shares (diluted)10.48M6.66M9.54M6.54M8.19M
Balance sheet
Cash & equivalents$10.41M$1.17M$184,686$475,076$421,549
Receivables$5.78M$67,000$1,290——
Inventory$5.03M$3.14M$4.42M——
Current assets$22.09M$4.92M$4.82M$250,704$1.16M
PP&E, net$318,000$196,000$490,920——
Total assets$23.02M$6.09M$6.71M$41.95M$233.63M
Current liabilities$7.87M$9.79M$7.34M$4.19M$633,641
Long-term debt$10.11M$9.93M———
Total debt$10.11M$9.93M———
Total liabilities$16.58M$15.62M$12.02M$13.42M$10.25M
Shareholders' equity$6.45M-$9.54M-$5.31M-$1.51M-$8.92M
Net debt-$303,000$8.76M———
Shares outstanding11.90M8.93M9.58M6.54M6.54M
Cash flow statement
Operating cash flow-$8.96M-$10.03M-$2.65M-$1.26M-$1.37M
Capital expenditure$124,000$88,000$13,040——
Free cash flow-$9.08M-$10.12M-$2.66M——
Investing cash flow-$124,000-$88,000-$13,040$192.24M-$232.30M
Financing cash flow$18.35M$11.13M$2.37M-$191.32M$234.09M
Depreciation & amortization$131,000$231,000$480,694——
Stock-based compensation$801,000$290,000$709,394—$95,200

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.